- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/205 - Radicals derived from carbonic acid
Patent holdings for IPC class C07D 295/205
Total number of patents in this class: 173
10-year publication summary
|
6
|
14
|
16
|
11
|
12
|
8
|
11
|
13
|
8
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| H. Lundbeck A/S | 1250 |
13 |
| Abide Therapeutics, Inc. | 26 |
7 |
| Amgen Inc. | 4076 |
5 |
| The Regents of the University of California | 19961 |
4 |
| The Scripps Research Institute | 1346 |
4 |
| Noramco, LLC | 27 |
4 |
| Libra Therapeutics, Inc. | 10 |
4 |
| Nxera Pharma UK Limited | 167 |
4 |
| Janssen Pharmaceutica N.V. | 3394 |
3 |
| FUJIFILM Corporation | 29437 |
3 |
| Sumitomo Chemical Company, Limited | 9043 |
3 |
| Dongguk University Industry-Academic Cooperation Foundation | 433 |
3 |
| Korea University Research and Business Foundation | 2991 |
3 |
| Metabolys | 7 |
3 |
| Mitsubishi Tanabe Pharma Corporation | 582 |
3 |
| Arvinas Operations, Inc. | 229 |
3 |
| AstraZeneca AB | 2892 |
2 |
| Boehringer Ingelheim International GmbH | 4642 |
2 |
| The Johns Hopkins University | 5675 |
2 |
| Northwestern University | 3398 |
2 |
| Other owners | 96 |